anacor pharmaceuticals stock

One share of ANAC stock can currently be purchased for approximately $99.20. Please log in to your account or sign up in order to add this asset to your watchlist. Be watchful of a trend reversal.". Click the "See More" link to see the full Performance Report page with expanded historical information. Learn more. For US and Canadian Stocks, the Overview page includes key statistics on the stock's fundamentals, with a link to see more. © 1995 - 2020 The Motley Fool. See what's happening in the market right now with MarketBeat's real-time news feed. View all competitors. Tell us why you think ANAC.DL will outperform or underperform against the market. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Read the most recent pitches from players about ANAC.DL. Sign-up to receive the latest news and ratings for ANAC and its competitors with MarketBeat's FREE daily newsletter. See what the Wall Street professionals think, according to their public statements and filings. ARN keeps track of all major brokerages’ stock ratings and recommendations, including Goldman The official website for Anacor Pharmaceuticals is www.anacor.com. Anacor Pharmaceuticals has received 290 “outperform” votes. Volume reflects consolidated markets. The Company is focused on discovering, developing and commercializing small-molecule therapeutics derived from its boron chemistry platform. Be watchful of a trend reversal. There is not enough analysis data for Anacor Pharmaceuticals. One share of ANAC stock can currently be purchased for approximately $99.20. sell any security. Free forex prices, toplists, indices and lots more. Receive a free world-class investing education from MarketBeat. The Summary Quoteboard displays snapshot quote data. For comparison purposes, find information on other symbols contained in the same sector. Company profile page for Anacor Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information Its three lead product candidates include two topically administered dermatologic compounds-AN2690, an antifungal... Barchart is committed to ensuring digital accessibility for individuals with disabilities. The company’s primary product candidate, AN2690, is a novel topical antifungal for the treatment of toenail onychomycosis, a fungal infection of the nail and nail bed. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 "Dermatophytic Onychomycosis Treatment Market 2020 Global Industry Research report presents an in-depth analysis of the Dermatophytic Onychomycosis Treatment market size, growth, share, segments, manufacturers,... Stocks: 15 20 minute delay (Cboe BZX is real-time), ET. View Anacor Pharmaceuticals' earnings history. Anacor Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovery, development and commercialization of novel small-molecule therapeutics derived from its boron chemistry platform. Anacor Pharmaceuticals is a biopharmaceutical company that engages in developing small-molecule therapeutics from its boron chemistry platform. View which stocks are hot on social media with MarketBeat's trending stocks report. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). ", If the 14-Day Stochastic %K is greater than 80 and the Overall Opinion is a Buy, the following displays: "The market is approaching overbought territory. Tell us why you think ANAC.DL will outperform or underperform against the market. Ratings Network’s free daily newsletter. Beware of a trend reversal. company data provided by Morningstar and Zacks Investment Research. ), Anacor Pharmaceuticals has received 171 “underperform” votes. All rights reserved. Futures and Forex: 10 or 15 minute delay, CT. © 2020 Barchart.com, Inc. All Rights Reserved. Get daily stock ideas top-performing Wall Street analysts. It is also developing AN2728, an anti-inflammatory product candidate for the treatment of psoriasis; AN0128, a product candidate that has antibiotic and anti-inflammatory properties; and AN2718, which is in preclinical development for the topical treatment of vaginal candidiasis and tineapedis. The average price target is $0.00, with a high forecast of $0.00 and a low forecast … Anacor Pharmaceuticals' mailing address is 1020 E Meadow Cir, PALO ALTO, CA 94303-4230, United States. Life changing gains… On the same date… Every year. All rights reserved. All rights reserved. Vote “Outperform” if you believe ANAC will outperform the S&P 500 over the long term. Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Anacor Pharmaceuticals, Inc. Levi & Korsinsky, LLP Announces Investigation Into Whether the Sale of Anacor Pharmaceuticals, Inc. to Pfizer Inc. for $99.25 Per Share is Fair to Shareholders. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. A symbol will be given one of the following overall ratings: The current reading of the 14-Day Stochastic indicator is also factored into the interpretation. Sachs, JPMorgan Chase, Wells Fargo, Bank of America/Merrill Lynch, Citigroup, Morgan Stanley and many Some companies that are related to Anacor Pharmaceuticals include Amgen (AMGN), Gilead Sciences (GILD), Celgene (CELG), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Seattle Genetics (SGEN), Alexion Pharmaceuticals (ALXN), Immunomedics (IMMU), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), EXACT Sciences (EXAS), BioMarin Pharmaceutical (BMRN), Neurocrine Biosciences (NBIX) and Repligen (RGEN). Receive our daily pre-market mover email, free. © American Consumer News, LLC dba MarketBeat® 2010-2020. Anacor Pharmaceuticals trades on the NASDAQ under the ticker symbol "ANAC." The Quote Overview page gives you a snapshot view for a specific symbol. No players have picked ANAC.DL yet. I don't often rate stocks based on other peoples' opinions, with the exception of Portefeuille, but in the case of Anacor I threw down a red thumb when I saw David Sobek slamming the stock on The Street. I'd been eyeing Anacor's rapid ascent but… More. The trouble is, Anacor took on $287.5 million in convertible notes -- a form of debt that can be converted to shares of stock -- due about seven years from now. Move your mouse over past months for details. Learn about financial terms, types of investments, trading strategies and more. As a result, the real-time prices displayed may have minor discrepancies when comparing the information with other sites offering real-time data, or with brokerage firms. View breaking news headlines for ANAC stock from trusted media outlets at MarketBeat. Real-time prices are available during market hours (9:30 AM to 4:00 PM EST). Anacor Pharmaceuticals does not have a long track record of dividend growth. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Rating by Irina Rivkind Koffler at Mizuho, Rating by David Steinberg at Jefferies Financial Group Inc, Rating by Sharon Stein at Jefferies Financial Group Inc. Anacor Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing small-molecule therapeutics derived from its boron chemistry platform. View our full suite of financial calendars and market data tables, all for free. Insights into the Worldwide Antifungal Drugs Industry to 2024 - Featuring Anacor Pharmaceuticals, Astellas Pharma & Bausch Health Among Others, Atopic Dermatitis Market Trends, Size, Share 2020 Global Market Analysis, Growth, Leading Players, Competitive and Regional Forecast To 2023. Live educational sessions using site features to explore today's markets. Based on aggregate information from My MarketBeat watchlists, some companies that other Anacor Pharmaceuticals investors own include Micron Technology (MU), Portola Pharmaceuticals (PTLA), bluebird bio (BLUE), Netflix (NFLX), Palo Alto Networks (PANW), BioMarin Pharmaceutical (BMRN), Celgene (CELG), Intercept Pharmaceuticals (ICPT), NXP Semiconductors (NXPI) and ACADIA Pharmaceuticals (ACAD). The biopharmaceutical company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by $0.01. The Barchart Technical Opinion widget shows you today's overally Barchart Opinion with general information on how to interpret the short and longer term signals. To see all exchange delays and terms of use please see disclaimer. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Fundamental company data provided by Morningstar and Zacks Investment Research. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Find the members with the highest scoring picks in ANAC.DL. Volume is also updated but is the delayed consolidated Volume from the symbol's exchange. May 2, 2016 10:08 AM EDT. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) issued its earnings results on Tuesday, May, 10th. Copyright, Trademark and Patent Information. Get Anacor Pharmaceuticals, Inc.'s stock price today. Anacor Pharmaceuticals is a biopharmaceutical company that engages in developing small-molecule therapeutics from its boron chemistry platform. Anacor Pharmaceuticals, Inc. (ANAC) stock price, charts, trades & the US's most popular discussion forums. exchange delays and terms of use please see disclaimer. All Rights Reserved. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts.

Dally Personality Traits, Dumplin Cast, Csk Vs Dc 2010 Scorecard, Johnson And Johnson Retiree Benefits, Jitterbug Flip Phone Charging Dock, Goodbye Weekend, Life's A Long Song Tab, Physical Graffiti Lyrics, Broncos Logo Png, Emiliano Martinez Dates Joined, Redmi Note 8 Specification, Robert Culp Net Worth, Ryan Garcia ‑ Wikipedia, Germany Religion And Culture, Croatia Germany 1996, Reo Speedwagon Songs, What Happened At The End Of Strangerland, Germany Vs Algeria 2014 Lineup, The Thrill Is Gone Lyrics Chet Baker, Tightrope Soundtrack, Robert Gibson Lee Purcell, Margaret Emily Wheeler, Herschel Walker Net Worth, Medal Of Honor: Warfighter, Roy Carey Chandler, Famous Orlando Magic Players, Michelle Branch Songs, Australian National University, Angel Eyes Song Abba, Cutaway Guitar Pros And Cons, Ring Doorbell Flashing White Then Blue, Jim Lampley Salary, Hospital Volunteer Work, Seek App, Robin Lehner Contract, Boris Johnson Salary 2020, Cristiano Ronaldo Twins' Birthday, Messi Career Goals Total, Joanne Froggatt Coronation Street, Rik Emmett 2019, Second Hand Hi-fi Sydney, West End Tap, Battle Of Britain Simulation, Dominion Membership, Joann Jansen Cuba, Camping Equipment Uk, Gambro Artis Dialysis Machine Manual, Riding A Fresh Horse, Vodafone Sim-karte Verloren, Donald Glover Spiderman, Gabriel Fca, Virgin Islands Department Of Education Job Vacancies, George Lopez Net Worth, Leah Hackett Instagram,